发明名称 |
BENZIMIDAZOLE-CARBOXAMIDE COMPOUNDS AS 5-HT4 RECEPTOR AGONISTS |
摘要 |
The invention relates to benzimidazole-carboxamide 5-HT4 receptor agonist compounds of formula (I);;wherein R1 and X are as defined in the specification, or a pharmaceutically acceptable salt or solvate or stereoisomer thereof. The invention also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5-HT4 receptor activity, and processes and intermediates useful for preparing such compounds. |
申请公布号 |
US2017081313(A1) |
申请公布日期 |
2017.03.23 |
申请号 |
US201615221841 |
申请日期 |
2016.07.28 |
申请人 |
THERAVANCE BIOPHARMA R&D IP, LLC |
发明人 |
McKinnell Robert Murray |
分类号 |
C07D401/14 |
主分类号 |
C07D401/14 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
SOUTH SAN FRANCISCO CA US |